tiprankstipranks

Strata Skin Sciences Highlights XTRAC® Laser Study Success

Story Highlights
  • STRATA Skin Sciences announced a study showing the XTRAC® Excimer Laser’s superior outcomes.
  • The study highlights deeper penetration and better pigmentation with fewer side effects.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Strata Skin Sciences Highlights XTRAC® Laser Study Success

Strata Skin Sciences ( (SSKN) ) just unveiled an announcement.

On March 20, 2025, STRATA Skin Sciences announced the publication of a study highlighting the superior clinical outcomes of their XTRAC® Excimer Laser over other UVB light sources like Excimer Light. The study, conducted by researchers from Nippon Medical School, demonstrated that the excimer laser’s unique technological characteristics, such as deeper penetration and greater activation of melanocyte lineage cells, result in better pigmentation and fewer side effects. This reinforces STRATA’s commitment to providing effective dermatological treatments and underscores their growing presence in Japan, where they have expanded significantly since 2019.

More about Strata Skin Sciences

STRATA Skin Sciences is a medical technology company focused on developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions such as psoriasis, vitiligo, and acne. Their offerings include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System, with a unique Partnership Program in the U.S. that includes a fee per treatment cost structure and comprehensive support services.

YTD Price Performance: -16.35%

Average Trading Volume: 5,318

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $11.26M

For detailed information about SSKN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App